A cohort study protocol to analyze the predisposing factors to common chronic non-communicable diseases in rural areas: Fasa Cohort Study by unknown
STUDY PROTOCOL Open Access
A cohort study protocol to analyze the
predisposing factors to common chronic
non-communicable diseases in rural areas:
Fasa Cohort Study
Mojtaba Farjam1,2, Hossein Bahrami3,4, Ehsan Bahramali1,5*, Javad Jamshidi1,6, Alireza Askari1, Habibollah Zakeri1,7,
Reza Homayounfar1, Hossein Poustchi8 and Reza Malekzadeh8
Abstract
Background: Non-communicable diseases (NCDs) have become the main causes of morbidity and mortality even
in rural areas of many developing countries, including Iran. In view of this increased risk, Fasa Cohort Study (FACS)
has been established to assess the risk factors for NCDs with the ultimate goal of providing optimal risk calculators
for Iranian population and finding grounds for interventions at the population level.
Methods: In a population-based cohort, at least 10,000 people within the age range of 35 to 70 years old from
Sheshdeh, the suburb of Fasa city and its 24 satellite villages are being recruited. A detailed demographic,
socioeconomic, anthropometric, nutrition, and medical history is obtained for each individual besides limited
physical examinations and determination of physical activity and sleep patterns supplemented by body
composition and electrocardiographic records. Routine laboratory assessments are done and a comprehensive
biobank is compiled for future biological investigations. All data are stored online using a dedicated software.
Discussion: FACS enrolls the individuals from rural and little township areas to evaluate the health conditions and
analyze the risk factors pertinent to major NCDs. This study will provide an evidence-based background for further
national and international policies in preventive medicine. Yearly follow ups are designed to assess the health
events in the participating population. It is believed that the results would construct a contemporary knowledge of
Iranian high risk health characteristics and behaviors as well as the platform for further interventions of risk
reduction in a typical Iranian population. Constantly probing for future advances in NCDs prevention and
management, the accumulated database and biobank serves as a potential for state of the art research and
international collaborations.
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Background
Iranian population is estimated to be more than
80,000,000 based on 2011 national census [1]. A few de-
cades ago, the main causes of mortality in Iran, like most
other developing countries, were communicable diseases
[2]. After operating the WHO recommendations regard-
ing disease control and by practicing prevention via
Iranian model of health network in rural and urban
areas, most communicable diseases were successfully
controlled and the mortality due to these diseases dra-
matically decreased [3]. Health interventions in rural
health houses and full-coverage vaccination were the
two effective preventive programs which largely contrib-
uted to this success. However, as expected, the non-
communicable diseases (NCDs) became more prevalent,
and indeed, collectively they became the main causes of
morbidity and mortality in the Iranian society such that
their share in all-cause mortality increase from 57 % in
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1990 to 76 % in 2010 [4]. These changes are similar to
the trends observed in many developing countries [5, 6].
It is generally believed that the reason for the emer-
gence of NCDs as the leading causes of morbidity and
mortality, is the change in people lifestyle [7]. Due to
modernization of the Iranian society, diet has been chan-
ged not only in the urban regions, but also in the rural
community [7]. Moreover, successful infectious disease
control and promotion of life standards has elongated
the life span and as a result, the number of people vul-
nerable to non-communicable diseases including cardio-
vascular, metabolic, renal and malignant diseases has
increased. With the alarmingly high prevalence of NCDs
in Iran [8], applying preventing strategies are of para-
mount importance. Prevention against NCDs is not
achievable by any single interventions. This is in contrast
to communicable diseases, and although research on the
development of vaccines for some NCDs are going on
[9–12], currently it is not a readily available option
worldwide. Till emergence of any paradigm shift in
NCDs, preventive measures as vaccines, different levels
of NCDs prevention should be defined in an evidence-
based manner which apparently demands systematic and
reliable data acquisition [13–16].
Ischemic heart disease, stroke, and other vascular dis-
eases, collectively considered as cardiovascular diseases
(CVD) encompass the major cause of death followed by
cancer [17]. Regarding CVDs compared to other diseases,
they have a handful of modifiable risk factors. Although
longitudinal studies to search for these modifiable risk fac-
tors date back to more than half a century ago in developed
countries, the discoveries achieved do not completely ad-
dress the developing world’s current health problems in
that these countries are not totally an equal match to the
developed societies. This is particularly important in view
of our previous work in a smaller cohort that showed that
the prevalence of common risk factors for CVD in Iranian
population is at high as American population [18]. Un-
doubtedly, baseline characteristics of the population stud-
ied, determine the risk estimates thus achieving to a precise
and accurate prognostic measure obligates a longitudinal
survey in the population of interest. Furthermore, the
somewhat unique aspects of the Iranian lifestyle as one of
the few ancient civilizations remained as a single country
today, as well as the ethnic diversities and considerable gen-
etic heterogeneity in this part of the world necessitate a
separate approach to look for the gene-environment inter-
actions as potential CV risk determinants.
According to the American Heart Association (AHA)
recommendations, coronary heart disease risk among
adults of 40 years of age and more without previous
CVD history ought to be determined every 5 years [19].
Conventional risk factors used in risk calculators though
proved to be accurate and reliable in different
populations, are not ideal in minor ethnicities and dis-
ease states like diabetes. Attempts are made as well to
incorporate other novel risk factors into the calculators
of risk to yield in a better risk stratification tool. There
are considerations at the same time about the imposed
financial burden of the components of the risk calcula-
tors related to the costly laboratory investigations for de-
veloping countries. While still more justifications are
needed to apply the AHA recommendations in develop-
ing countries, a recent study, has focused on the recali-
bration of the Framingham office-based CV risk
calculator and reported that the measures obtained from
history, physical examinations and anthropometric in-
dexes can be used comparably to yield in similar risk es-
timates at the lowest cost compared to the available
accepted laboratory based risk calculators [20].
Regarding the mentioned shortcomings with the avail-
able tools for determination of CVDs risk in Iran, look-
ing for more readily available means taking into account
the ethnic diversities, limited financial resources and the
advantages of an established primary health care net-
work seems mandatory. Cohort studies are of special im-
portance to analyze the risk factors of predisposition to
NCDs. This will also significantly contribute to designing
preventive strategies by the policy makers. The cohort
data can be used in organization of almost all levels of
disease prevention and evidence-based real-time algo-
rithm tailoring in both preventive and clinical issues [16,
21]. Fasa University of Medical Sciences (FUMS), an in-
stitute dedicated to improving the health standards, [22]
has planned to build up a population-based cohort study
in its territory to acquire an image of the NCDs preva-
lence and incidence and at the same time research on
the related risk factors. This is under the supervision of
the deputy for research and technology of the Iranian
ministry of health (MOH).
Methods/design
Participant recruitment
Fasa cohort study (FACS) has been designed to evaluate
the risk factors pertinent to predisposing the inhabitants
of the rural region of Fasa to NCDs including the most
common ones. The study is a population-based longitu-
dinal survey with a total follow- up span of 15 years.
People are invited to participate in the study by the rural
health care worker (Behvarz), the representatives of the
primary health care system in every health house in the
villages and small towns [23]. Behvarz knows every sin-
gle individual invited and their health status having reg-
istered all villagers of his or her territory in the first
place. In Iranian model of the health network, Behvarz is
of extraordinary importance as she/he have been selected
from the habitants of same towns and villages and have
underwent special training programs before they started as
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the health care worker in the primary health care network.
They cover a population of around 200–2000 population
and are in direct contact with people of their region with
routine and programmed follow ups and recordings of
basic health status of their region. Behvarz follow ups are
held in the health houses where she regularly visits people
and performs basic physical examinations such as blood
pressure control as well as health events recordings. Beh-
varzes served as the inviters to the FACS because they were
familiar with every habitant of the region and people trust
them. They have been briefed about the study protocol and
goals in special training sessions by the PIs of the study.
Upon a well-rehearsed method, Behvarzes counted and in-
vited every eligible habitant of the region in a clockwise
manner eventually selecting every living place from the
health house.
Target region and target population
Fasa city is located in the eastern part of the province of
Fars, in southwest of Iran with a population of about
250,000. A rural region known as Sheshdeh (28°56′56.0″N
53°59′26.9″E) with a total population of 41,000 was chosen
for the cohort study. People within the age range of 35–70
years (11,097 individuals) were planned to participate as the
target population in the cohort since they are old enough
that have been exposed to health threads and risk factors
and young enough not to develop CV events and NCDs
endpoints. With the planned follow up time of 15 years
they’re expected to experience study outcome variables
with the highest possible rate.
The ethnicities of people living in this region is di-
verse, including Fars, Turks and Arabs. They live in a
small town (Sheshdeh) and 24 surrounding villages. The
name of these districts and their population of 35–70
years old are represented in Fig. 1.
The field office
An office in the field was funded in the main town of
the region. The building has one reception desk and 12
rooms for samplings, physical examinations and inter-
views. Waiting rooms are equipped with display moni-
tors that constantly guide people through different steps
of enrollment process. All essential equipment including
computers, sampling facilities and physical exam devices
are provided in the field.
The laboratory
The laboratory is located in the NCD research center
central laboratory at FUMS. State of the art laboratory
facilities are available for processing the samples. A bio-
bank with five −70 °C refrigerators and UPS system to
control the electricity equipped with real time
temperature and electricity controller has been provided.
Human resources
A field team works daily in the field office. The team
consists of a field supervisor, two physicians, inter-
viewers, nurses, sampling technicians, driver and office
boy. Field supervisor is in charge for surveillance of the
ongoing interviews and monitoring that data acquisition
is carried out according to the protocols.
All personnel have been selected from a number of eli-
gible volunteers after a primary interview and upon a
completed training course in the MOH. All of them have
been approved through detailed tests after training
workshops. The interviewers have been practically
trained to ask questions from the participants using
digital data acquisition sheets in addition to valid and
standard questionnaires and screening tools. They are
divided into general, medical and nutrition interviewers
based on the questionnaire type they administer. They
have academic degrees from bachelor to master related
to their job. Four Laboratory technicians and a lab
supervisor work in the laboratory. The laboratory
personnel have been selected by exams after training
about the cohort. They are familiar with the details of
coding process, laboratory issues and biobank manage-
ment and work under direct supervision of laboratory
supervisor. The supervisor is responsible for laboratory
coding, recording and biobank organization. All lab
people are familiar with the cohort protocols and have
academic degrees in the field of medical laboratory
sciences.
A scientific team of principal investigators (PIs) in-
cluding cardiologist, nutritionist, pharmacologist, epi-
demiologist, geneticist and anesthesiologist specialized
in pain management supervises the cohort working both
in the field and the headquarters. All PIs are academic
investigators affiliated to Fasa, Shiraz and Tehran univer-
sities of medical sciences and have been updated regard-
ing the cohort study. They are responsible for all
executive and scientific processes. They supervise thfe
process of data gathering and laboratory function, ob-
serve the administrative issues related to the project and
data cleaning and perform the quality control proce-
dures of the data. The scientific analysis of the variables
is done by this team regularly. The main PI is the corre-
sponding manager who chooses the field supervisor.
Work steps in the field office
A schematic presentation is provided in Fig. 2.
Step 1- Registration
The registration process is based on national IDID code
of each individual. The field supervisor registers partici-
pants by checking their ID cards and a unique number
is attributed to each one (PCID) and from then on, it
will be available on all questionnaires, forms and sample
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tubes. One of the interviewers also helps field supervisor
with the registration. In all steps of the cohort study,
PCID is searchable. A cohort ID card will be issued at
the same time, with the digital bar code, photo and the
attributed number. A registry is also performed in a sep-
arate notebook. The registered individual should be
checked against the previously prepared list of the in-
vited participants by the Behvarz. For every participant,
an informed consent letter is filled before registration.
All the questionnaires are electronic, using a dedicated
online software. We used the advantage of electronic
questionnaires for improving the accuracy and validity
of the entered data. They were designed to be smart in a
way that potentially inaccurate data, pre specified out-
liers or invalid variable types are highlighted and the
data entry doesn’t proceed unless the registrar rechecks
and accepts the entry.
Step 2- Anthropometrics measurement
In this step, weight, height, and an estimation of body
water is evaluated by using Bioelectrical impedance ana-
lysis (tanita BC-418, tanita corp, japan) for every
participant.
Step 3- Laboratory sampling
For this cohort, the collection and saving of samples are
of extreme importance. Invitees have been asked not to
trim or color their hair and nails for 2–4 weeks and
maintain fasting state for 10–14 h prior to referral.
Blood, urine, hair and nail samples are taken from all
the participants. The sampling is done by professional
sampling personnel using modern tools. Samples are
kept in codified tubes and containers.
A total of 25 ml of blood is taken, comprising one 7-
ml clot tube and three 6-ml EDTA tubes. About 15 ml
Fig. 1 The location and the name of Fasa Cohort Study districts and their population of 35–70 years old
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of urine is taken from every participant. Nail and hair
are taken too. At least 1 mm of all nails of hand and foot
carried in aluminum foil is kept in zip keeps containing
humid absorber. For hair samples, occipital hair is taken
from the hair root and put in zip keep bags in which hu-
midity absorber is included.
Step 4- Electrocardiography
All participants have 12-lead electrocardiograms (EKG)
recorded before the interviews. They are asked to shave
their precordium at the time of invitation for the best
possible result attained. EKGs are all stored in the stand-
ard format (Health Level-7) and a dedicated software
(Cardiax®) automatically makes diagnoses and provides
electronic data exports to be incorporated into the cen-
tral data acquisition software. Automatic diagnoses will
be reviewed by cardiologists further upon the related re-
search protocols per needed. Totally 156 parameters are
recorded for each participant per EKG which includes
12-lead deflection voltage amplitudes, durations, inter-
vals and ST segment deviations as well as heart rate and
vector analyses. Data quality is assessed each month
after interpretations by the steering committee.
Step 5- Interviews to fill the questionnaires
General interview In this section, the general character-
istics of the participants are recorded. The general ques-
tionnaire is subdivided to nine sections comprising
personal information, general information, socioeco-
nomic status, occupational status, home location and
type of fuel used, lifestyle, anthropometric measure-
ments, mobile use, and pesticide use. In each subsection
the detailed information for every participant is recorded
(details of the questionnaire are available at ncdrc.fum-
s.ac.ir/collaboration).
Medical interview Data acquisition forms are filled in
asking about any previous medical history of every par-
ticipant. Validated screening questionnaires are utilized
as well to obtain data on the incident common NCDs,
dental health, physical activity, sleep quality and dur-
ation, fertility, substance and alcohol abuse and smoking.
The full length data gathering sheet and questionnaire is
available at ncdrc.fums.ac.ir. Participants are also asked
to bring their medications at the time of interview to
register the drug history with maximum precision. His-
tory of prior hospitalizations are recorded and a positive
family history for NCDs are sought.
Nutrition interview The modified food frequency ques-
tionnaire (FFQ) is administered in this phase to evaluate
the eating habits and foods consumed by the partici-
pants. The FFQ is a semi-quantitative 125-item inven-
tory. The inventory is used to obtain information on
dietary intake over a 1-year period and is a Willett for-
mat questionnaire [24] modification based on Iranian
food items. It includes a list of foods (with standard
serving sizes) commonly consumed by Iranians. Individ-
uals are requested to report their frequency of consump-
tion of a given serving of each food item during the past
year, on a daily, weekly, monthly or yearly basis. A
standard portion size is designated for each item by
using United States Department of Agriculture (USDA)
serving sizes (e.g. bread, one slice; dairy, one cup).
Step 6- Physical exam
Five nurses are in charge for taking resting heart rate
and blood pressure, examining the oral hygiene, inspect-
ing for alopecia and/or hirsutism, analyzing the partici-
pants’ posture and looking for the gross abnormalities in
limbs and torso. They are trained to measure and record
the blood pressure in both arms consecutively. After
15 min repeated measurements are done and recorded.
Heart rate is recorded in sitting position 15 min apart as
well. Initially all the nurses were granted with a certifi-
cate after completing the training courses and every
3 months, they have received repeated instruction for
certificate renewal.
Laboratory work in the lab
After taking samples from participants in the field, they
are transferred in cool boxes to the laboratory for pro-
cessing. Different laboratory data are provided for each
participant. These include complete blood count (CBC);
Fig. 2 the schematic presentation of registration process in the field
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blood biochemical parameters measurements (fasting
blood sugar (FBS), serum total cholesterol (TC), trigly-
ceride (TG), high density lipoprotein (HDL) and low
density lipoprotein (LDL) cholesterol, alanine amino-
transferase (ALT), asparagine aminotransferase (AST),
alkaline phosphatase, gamma glutamyl transpeptidase,
urea, and creatinine levels and urine analysis (color, spe-
cific gravity, appearance, PH, nitrite, bilirubin, urobilino-
gen, protein, glucose, and blood). The laboratory data
are recorded in an electronic database. These data then
are imported to the main database including every par-
ticipant detailed information which were recorded
through the questionnaires.
Sample saving
For blood specimen saving, 1.4 ml 2D crayotubes are
used. There are smart 12-digit code on every tube which
can be read by smart scanner. Twelve cryotubes are pre-
pared as represented in the Table 1.
The cryotubes are stored in −70 refrigerators. The
samples are put with a specific order in the box codified
for every individual participant.
The follow-up phase
This study includes a 15-year follow- up phase. As one
of the important pitfalls of follow-up phase could be lack
of knowledge in staffs, every individual who is in charge
of follow up will be educated for understanding their
role before the follow up starts. The follow up data will
be recorded in a software which is designed especially
for this purpose.
The follow up team comprises a physician/nurse, in-
terviewers (which are preferably nurses) and a laboratory
technician. They are responsible for yearly follow up and
work under the supervision of the main PI and the field
director. An outcome review team including three inter-
nists along with follow-up team will determine the final
diagnosis or the cause of any death of participants. At
the time of enrolment every participant signs an in-
formed consent in order to let the follow-up team to ac-
cess their past and future medical records.
There are two types of follow-up, passive and active.
In passive follow-up the data will be gathered through
self-reports and reports of diseases and cancer registry
centers (and also other centers related to health services
such as: private clinics, general physicians, forensics
centers, medical insurance, laboratories). The deaths will
be recorded and if an outcome of interest (such as car-
diovascular diseases and cancer) was confirmed in a par-
ticipant, the participants will be invited to the laboratory
and blood sample will be taken from them. Besides get-
ting data via passive reports, most cases will be
followed-up actively using phone interviews by the phys-
ician or the interviewers in yearly intervals. If there was
no answer in a phone call after six times in three differ-
ent days of 3 weeks, the follow-up team will go to the
postal address of the participant and interview will be
done face to face. Behvarzes will facilitate this process.
The deaths will be recorded and in case of outcome of
interest, the participants will be invited to the laboratory
and blood sample will be taken from them.
To investigate changes in risk or protective factors of
diseases, in 5, 10 and 15th years of follow-up (2nd, 3rd
and 4th Screenings), the re-sampling (blood, urine, hair
and nail) will be carried out and new lifestyle question-
naire and FFQ will be filled out for all alive participants.
Quality control
Surveillance systems are of crucial importance and the
quality control team at the initial enrollment phase has a
practically validated checklist to clearly address a variety
of quality measures of data collection. The team super-
visor is an epidemiologist who is not one of the investi-
gators of FACS. They cover all three aspects of the data
and specimen acquisition process: general questionnaires
and anthropometric measurements, medical and disease
screening questionnaires, and biologic samples acquisi-
tion and biobank maintenance. Furthermore, the control
will be operated every 3 months by an external reviewer
who is familiar with the entire process of registration at
FACS. If any draw backs observed, they would be taken
into consideration for the following clean up phase. The
quality control administrator who is one of the PIs has
full access to the database and codified information. In
case of any need for clean up another team member re-
trieves the codified data for the cleanup.
The FACS software is designed to make basic checks
automatically as well. Data fields are sensitive to outliers
which has been defined by the investigators and the soft-
ware alarms the operators to confirm the values they are
entering before the final registration. Inaccurate data in
terms of variable types, length and measurement levels
are also identified and the final approval depends on an
extra step of PI validation.
Discussion
There are gaps between research-based evidence,
health policies and clinical practice in developing
countries [25]. Incorporating the evidence provided by
studies in developing countries into policy making is
Table 1 Saved samples during the study for every individual
Sample Number of cryotubes Volume (ml)
Whole blood 2 1
Plasma 6 1
Buffy coat 2 1
Serum 2 1
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a critical step in improving the health status in these
countries [26, 27]. Acknowledging that, FACS was
founded by NCD research center to contribute to tai-
loring Iranian evidence-based health and medical pol-
icies. By this view, and by the support of the MOH,
some major management barriers such as the limita-
tions in financial and human resources [28] were
overcome. Technical issues were solved by means of
several expert sessions at the MOH and using the
opinions of international collaborators. The health
deputy in Fasa also played a special role in offering
its network facilities for recruitment of the people.
One problem might be the immigration of the par-
ticipants. To address that we engaged actively in the
development of a nationwide health indexes registra-
tion system (SIB network) which actively records
every Iranian’s health status by means of an online
software. The software allows tracking of people in
the health network and facilitates the outcome mea-
surements for FACS. The two disease registration sys-
tems available in FUMS as population-based registry
for myocardial infarction (FaRMI) and hospital-based
registry for systolic heart failure (FaRSH) are custom-
ized as well to notify the investigators of FACS in
case of any incident outcomes for FACS participants.
Death registers are also reviewed weekly by the follow
up team and are checked against the national IDs of
participants registered in FACS.
To further support national and international collabo-
rations, the data will be available to investigators who
accept terms and conditions noted in the official website
of the FACS (ncdrc.fums.ac.ir). The laboratory will con-
tinue functioning in later phases and the biobank will be
operating and ready to be used for researchers and col-
laborators who like to investigate in the field after
authorization by the steering committee.
Abbreviations
AHA: American heart association; ALT: Alanine aminotransferase;
AST: Asparagine aminotransferase; CBC: Complete blood count;
CVD: Cardiovascular diseases; EDTA: Ethylenediaminetetraacetic acid;
EKG: Electrocardiograms; FACS: Fasa cohort study; FBS: Fasting blood sugar;
FFQ: Food frequency questionnaire; FUMS: Fasa University of Medical
Sciences; HDL: High density lipoprotein; LDL: Low density lipoprotein;
MOH: Ministry of health; NCD: Non-communicable diseases; PCID: Persian
cohort ID; PIs: Principal investigators; TC: Serum total cholesterol;
TG: Triglyceride; USDA: United States department of agriculture; WHO: World
health organization
Acknowledgements
The authors would like to thank the personnel of the NCD research center at
FUMS for their keen efforts and enthusiasm toward the study. Mrs. Soroush
Dadvari, Mona Rajabi MD and Samaneh Yousefi MD are especially thanked
for their great support and brilliant help with the field and laboratory works.
Authors would also appreciate the efforts made by the central quality
control team who were involved in instructing the interviewers and further
monitoring of their performance; especially Zahra Mahmoudi, Sareh
Eghtesad, Ameneh Shayanrad and Romina Mohammadi.
Funding
This research was funded by the Islamic Republic of Iran Ministry of Health
grants for development of cohort studies.
Availability of data and materials
Data sharing not applicable to this article as no datasets were generated or
analyzed during the current study. The general information is available from:
http://ncdrc.fums.ac.ir/.
Authors’ contributions
MF, HB, EB, HP and RM were seriously involved in the conception and the
design of the study. MF, EB, AA, HZ and JJ critically revised the protocol and
EB, JJ and RH were involved in the analysis of the process and the initial
results. Local steering committee consisted of MF, EB, JJ, AA, HZ and RH who
supervised the adherence to the protocol in a weekly basis. EB, HB, MF and
JJ were the major authors who wrote the initial draft and EB, HB, HP and RM
critically revised the final manuscript. All authors finally revised and approved
the manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
This study is in agreement with the Helsinki declaration and Iranian national
guidelines for ethics in research. The protocol of the study was approved by
the regional and national research ethics committees (equivalent of
institutional review boards) of FUMS, (reference number: IR.FUMS.RES.1394.3).
All participants were asked to sign a written informed consent approved by
the research ethics committee. The participants are able to withdraw from
the study when they wish. Data collected are stored in a codified
confidential database.
Author details
1Noncommunicable Diseases Research Center, Fasa University of Medical
Sciences, Fasa, Iran. 2Department of Medical Pharmacology, Fasa University
of Medical Sciences, Fasa, Iran. 3Division of Cardiovascular Medicine,
Department of Medicine, Keck School of Medicine, University of Southern
California, Los Angeles, USA. 4Department of Preventive Medicine, Keck
School of Medicine, University of Southern California, Los Angeles, USA.
5Cardiology Department, Fasa University of Medical Sciences, Fasa, Iran.
6Department of Medical Genetics, Fasa University of Medical Sciences, Fasa,
Iran. 7Anesthesiology Department, Fasa University of Medical Sciences, Fasa,
Iran. 8Digestive Diseases Research Institute, Tehran University of Medical
Sciences, Tehran, Iran.
Received: 1 September 2016 Accepted: 11 October 2016
References
1. National Population and Housing Census, 2011. [https://www.amar.org.ir/
english/Statistics-by-Topic/Population#2224493-releases].
2. Askarian M, Mansour Ghanaie R, Karimi A, Habibzadeh F. Infectious diseases
in Iran: a bird’s eye view. Clin Microbiol Infect. 2012;18(11):1081–8.
3. Moghadam MN, Sadeghi V, Parva S. Weaknesses and challenges of primary
healthcare system in Iran: a review. Int J Health Plann Manag. 2012;27(2):
e121–31.
4. Naghavi M, Shahraz S, Sepanlou SG, Dicker D, Naghavi P, Pourmalek F,
Mokdad A, Lozano R, Vos T, Asadi-Lari M, et al. Health transition in Iran
toward chronic diseases based on results of Global burden of disease 2010.
Arch Iran Med. 2014;17(5):321–35.
5. Jamal R, Syed Zakaria SZ, Kamaruddin MA, Abd Jalal N, Ismail N, Mohd
Kamil N, Abdullah N, Baharudin N, Hussin NH, Othman H, et al. Cohort
profile: The Malaysian Cohort (TMC) project: a prospective study of non-
communicable diseases in a multi-ethnic population. Int J Epidemiol. 2015;
44(2):423–31.
6. Teo K, Chow CK, Vaz M, Rangarajan S, Yusuf S, Group PI-W. The Prospective
Urban Rural Epidemiology (PURE) study: examining the impact of societal
Farjam et al. BMC Public Health  (2016) 16:1090 Page 7 of 8
influences on chronic noncommunicable diseases in low-, middle-, and
high-income countries. Am Heart J. 2009;158(1):1–7. e1.
7. Ghasemian A, Ataie-Jafari A, Khatibzadeh S, Mirarefin M, Jafari L, Nejatinamini S,
Parsaeian M, Peykari N, Sobhani S, Jamshidbeygi E, et al. National and sub-
national burden of chronic diseases attributable to lifestyle risk factors in Iran
1990–2013; study protocol. Arch Iran Med. 2014;17(3):146–58.
8. Ostovar A, Nabipour I, Larijani B, Heshmat R, Darabi H, Vahdat K, Ravanipour
M, Mehrdad N, Raeisi A, Heidari G, et al. Bushehr Elderly Health (BEH)
Programme, phase I (cardiovascular system). BMJ Open. 2015;5(12):e009597.
9. Farjam M, Zhang GX, Ciric B, Rostami A. Emerging immunopharmacological
targets in multiple sclerosis. J Neurol Sci. 2015;358(1-2):22–30.
10. Bairwa M, Pilania M, Gupta V, Yadav K. Hypertension vaccine may be a boon to
millions in developing world. Hum Vaccin Immunother. 2014;10(3):708–13.
11. Menard J. A vaccine for hypertension. J Hypertens. 2007;25(1):41–6.
12. McKee SJ, Bergot AS, Leggatt GR. Recent progress in vaccination against human
papillomavirus-mediated cervical cancer. Rev Med Virol. 2015;25 Suppl 1:54–71.
13. Bray F, Soerjomataram I. The changing global burden of cancer: transitions
in human development and implications for cancer prevention and control.
In: Gelband H, Jha P, Sankaranarayanan R, Horton S, editors. Cancer: disease
control priorities, vol. 3. Third Editionth ed. Washington (DC); 2015.
14. Konchak JN, Moran MR, O’Brien MJ, Kandula NR, Ackermann RT. The state of
diabetes prevention policy in the USA following the affordable care act.
Curr Diab Rep. 2016;16(6):55.
15. Ohira T. Evaluation of cardiovascular risk prediction for the guidelines of
cardiovascular diseases prevention in Japan. J Atheroscler Thromb. 2016;
23(2):169–70.
16. Fakhraei B, Farjam M. Evidence- based hypotheses about levels of
prevention of multiple sclerosis: current findings, future prospects. La Prensa
Medica Argentina. 2014;100:3.
17. Forouzanfar MH, Sepanlou SG, Shahraz S, Dicker D, Naghavi P, Pourmalek F,
Mokdad A, Lozano R, Vos T, Asadi-Lari M, et al. Evaluating causes of death
and morbidity in Iran, global burden of diseases, injuries, and risk factors
study 2010. Arch Iran Med. 2014;17(5):304–20.
18. Bahrami H, Sadatsafavi M, Pourshams A, Kamangar F, Nouraei M, Semnani S,
Brennan P, Boffetta P, Malekzadeh R. Obesity and hypertension in an Iranian
cohort study; Iranian women experience higher rates of obesity and
hypertension than American women. BMC Public Health. 2006;6(1):158.
19. Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP, Franklin BA,
Goldstein LB, Greenland P, Grundy SM. AHA guidelines for primary prevention
of cardiovascular disease and stroke: 2002 update consensus panel guide to
comprehensive risk reduction for adult patients without coronary or other
atherosclerotic vascular diseases. Circulation. 2002;106(3):388–91.
20. Sepanlou SG, Malekzadeh R, Poustchi H, Sharafkhah M, Ghodsi S,
Malekzadeh F, Etemadi A, Pourshams A, Pharoah PD, Abnet CC. The clinical
performance of an office-based risk scoring system for fatal cardiovascular
diseases in North-East of Iran. PLoS One. 2015;10(5):e0126779.
21. Penning-van Beest FJ, Termorshuizen F, Goettsch WG, Klungel OH, Kastelein
JJ, Herings RM. Adherence to evidence-based statin guidelines reduces the
risk of hospitalizations for acute myocardial infarction by 40 %: a cohort
study. Eur Heart J. 2007;28(2):154–9.
22. Ronaghy HA, Nasr K. Fasa University Medical School: a novel experience in
medical education. J Adv Med Educ Prof. 2014;2(1):51–2.
23. Soori H, Motlagh E. Iranian rural health workers (behvarz) and risk factors of
childhood injury. East Mediterr Health J. 1999;5(4):684–9.
24. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens
CH, Speizer FE. Reproducibility and validity of a semiquantitative food
frequency questionnaire. Am J Epidemiol. 1985;122(1):51–65.
25. Guindon GE, Lavis JN, Becerra-Posada F, Malek-Afzali H, Shi G, Yesudian CA,
Hoffman SJ, Research to P, Practice Study T. Bridging the gaps between
research, policy and practice in low- and middle-income countries: a survey
of health care providers. CMAJ. 2010;182(9):E362–72.
26. Guindon GE, Lavis JN, Boupha B, Shi G, Sidibe M, Turdaliyeva B, Research to
P, Practice Study T. Bridging the gaps among research, policy and practice
in ten low- and middle-income countries: development and testing of
questionnaire for health-care providers. Health Res Policy Syst. 2010;8(1):3.
27. Newquist DD, DeLiema M, Wilber KH. Beware of data gaps in home care
research: the streetlight effect and its implications for policy making on
long-term services and supports. Med Care Res Rev. 2015;72(5):622–40.
28. El-Jardali F, Jamal D, Abdallah A, Kassak K. Human resources for health
planning and management in the Eastern Mediterranean region: facts, gaps
and forward thinking for research and policy. Hum Resour Health. 2007;5:9.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Farjam et al. BMC Public Health  (2016) 16:1090 Page 8 of 8
